Antifungal susceptibility of invasive yeast isolates in Italy: the GISIA3 study in critically ill patients.

MLA

Morace, Giulia, et al. “Antifungal Susceptibility of Invasive Yeast Isolates in Italy: The GISIA3 Study in Critically Ill Patients.” BMC Infectious Diseases, vol. 11, May 2011, p. 130. EBSCOhost, https://doi.org/10.1186/1471-2334-11-130.

APA

Morace, G., Borghi, E., Iatta, R., Amato, G., Andreoni, S., Brigante, G., Farina, C., Lo Cascio, G., Lombardi, G., Manso, E., Mussap, M., Pecile, P., Rigoli, R., Tangorra, E., Valmarin, M., & Montagna, M. T. (2011). Antifungal susceptibility of invasive yeast isolates in Italy: the GISIA3 study in critically ill patients. BMC Infectious Diseases, 11, 130. https://doi.org/10.1186/1471-2334-11-130

Chicago

Morace, Giulia, Elisa Borghi, Roberta Iatta, Gerardino Amato, Stefano Andreoni, Gioconda Brigante, Claudio Farina, et al. 2011. “Antifungal Susceptibility of Invasive Yeast Isolates in Italy: The GISIA3 Study in Critically Ill Patients.” BMC Infectious Diseases 11 (May): 130. doi:10.1186/1471-2334-11-130.